A Comprehensive Study of Chronic Diabetes Complications in Streptozotocin-Induced Diabetic Rat by Al-Mahmood, S. M. (Sinan) et al.
Makara J. Health Res., 2016, 20(2): 48-56 
doi: 10.7454/msk.v20i2.5889 
August 2016 | Vol. 20 | No. 2 48
A Comprehensive Study of Chronic Diabetes Complications in  
Streptozotocin-Induced Diabetic Rat 
 
Sinan MA Al-Mahmood1*, Tariq A Razak2, Shahrin T Che Abdullah2,  
Nik N Fatnoon Nik Ahmad2, Abdul H Mohamed2, Imad M Al-Ani2 
 
1. Department of Nursing, International Islamic University Malaysia, 25710 Kuantan, Pahang Darul Makmur, Malaysia 
2. Department of Medicine, International Islamic University Malaysia, Bandar Indera Mahkota Campus,  
25200 Kuantan, Pahang Darul Makmur, Malaysia 
 
*E-mail: sinanmohamed@iium.edu.my 
 
 
Abstract 
 
Background: The purpose of this study was to provide a reference of chronic diabetes complications by investigating 
the prolonged hyperglycemia effects on hematological, biochemical and histopathological changes (liver, kidney, 
spleen, cardiac muscle, adrenal gland, and endocrine pancreas) in diabetic rats induced by streptozotocin. Methods: 
Ten adult female Sprague-Dawley of uniform age were divided into two Groups. Group 1 was made diabetic by single 
intraperitoneal injection of streptozotocin (60 mg/kg/bw) whereas Group 2 served as control. After six months, the rats 
were anaesthetized using pentobarbital. Cardiac puncture was performed to get 3 ml of the blood sample; following 12 
hours of an overnight fast. Serum chemistry test and complete blood analysis for lipid profile and blood glucose test; 
liver and renal functions were performed. Tissue specimens of liver, kidney, spleen, cardiac muscle, adrenal gland, and 
endocrine pancreas were fixed in 10% formal saline and processed for histological study. Results: There were severe 
histopathological changes in the affected organs; and the presence of a significant abnormality of lipid profile, liver, and 
renal functions. Conclusions: The presence of histopathological changes with abnormal biochemical changes is related 
to the chronic absence of insulin production in the destroyed β–cells which reflect the diabetic complications in a 
human being. 
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Introduction 
 
Diabetes mellitus (DM) is the commonest metabolic 
diseases characterised by hyperglycemia resulting from 
deficiencies in insulin secretion or action or both; that 
affects carbohydrate, lipid, protein and nucleic acid 
metabolism. According to the international diabetes 
federation (IDF), more than 382 million adults throughout 
the world suffered from diabetes, and 5.1 million deaths 
occur yearly due to diabetes.1 The frequency of diabetes 
has doubled in the last three decades, and it is predicted 
to continue rising to 592 million cases by 2,035
.
1
 
Experimental models of diabetes have been developed 
by using drugs such as Streptozotocin (STZ) to induce 
diabetes. These drugs inflate and ultimately destruct the 
β-cells of the pancreatic islets. STZ is an antimicrobial 
agent; initially developed as an antibiotic and antitumor 
agent.2 It is now widely used to induce diabetes mellitus 
in many animal species resembling many features seen in 
human patients’ condition including clinical, physiological 
and pathological features. STZ is the first choice for 
diabetes induction in animals, mild to severe diabetes 
are generated depending on the animal strain, dose, period 
and route of drug administration.3 A single intraperitoneal 
injection of STZ (150 mg/Kg body weight) or multiple 
intraperitoneal injections of low dose (40 mg/Kg body 
weight) in mice produced a significant hyperglycemia 
similar to a type 1 diabetic. Mild diabetes, characterised 
by low glycemic intensity, was induced in rats received 
100mg/kg STZ injection subcutaneously.4,5 Mild diabetes 
was also observed in rats injected intraperitoneally with 
a single dose of 100mg/kg of STZ.6,7 It was found that a 
single i.p. Injection of 100 mg/kg STZ in mice produced 
non-insulin-dependent DM characterised by impaired 
insulin response to glucose stimulation while 200 mg/kg 
STZ-induced insulin-dependent DM.8 The purpose of 
this study was to provide a reference of chronic diabetes 
complications by investigating the prolonged complications 
of untreated diabetes on hematological, biochemical and 
histopathological changes (liver, kidney, spleen, cardiac 
muscle, adrenal gland, and endocrine pancreas) in untreated 
diabetic rats after six months of treatment with STZ. 
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Methods 
 
Animals and experimental design. Ten adult female 
Sprague-Dawley rats (weighing 200-225 g, 12 weeks 
old) were used. All experimental rats were kept in cages 
under the standard laboratory conditions (adequate cross 
ventilation; temperature: 22 ± 1 °C; 12:12 hrs light: dark 
cycle; relative humidity: 60-70%) and were allowed one 
week period to acclimatise before the experiment. The 
rats were maintained on standard commercial dry pellet 
diet and water ad libitum. The rats were randomly 
divided into two groups of 5 animals, control group and 
STZ treated group. STZ (Merck) was dissolved in 0.1M 
citrate buffer PH 4.5 immediately before i.p. Injection. 
Following an overnight fast, diabetes was induced under 
light anaesthesia (Sodium pentobarbital) by a single 
intraperitoneal injection of 60 mg/kg of STZ. Rats were 
supplied with 5% glucose solution for 24 hrs. 
Immediately after STZ injection to prevent the severe 
acute hypoglycemic effect. The rats of the control group 
received an equivalent volume of i.p injection of Citrate 
Buffer only. Three days post induction, fasting blood 
glucose level was measured, only rats with fasting blood 
sugar (FBS) level ≥ 15 mmol/L were considered as 
diabetic rats.  
 
Collection of blood samples and biochemical assays. 
All rats were anaesthetized with pentobarbital (90 
mg/kg). The blood samples (3 ml) of each animal were 
withdrawn by cardiac puncture; following an overnight 
fast for 12 hrs. All blood samples preserved with 
suitable blood tube with specific agents. Serum 
chemistry test and complete blood analysis were 
performed in Biochemistry and Hematology Unit 
(Faculty of Medicine, International Islamic University 
Malaysia). 
 
Histological studies. After six months, fasting blood 
glucose level was measured, animals from control and 
treated groups (STZ) were sacrificed by using mild 
anaesthesia (Sodium pentobarbital 90 mg/kg); dissected 
and small pieces of different organ (Pancreas, liver, 
kidney, spleen, cardiac muscle and adrenal gland) were 
quickly removed, fixed in 10% formal saline for 72 hrs., 
dehydrated through graded alcohols and processed for 
light microscopy. Sections of (4-5 µ thickness) were 
stained with Ehrlich Haematoxylin and Eosin.   
 
Statistical analysis. Data analyses were performed 
using statistic software IBM SPSS Statistics 20 (IBM 
Corporation, NY, USA). All data in this study are 
presented as mean ± SEM. Data were analysed by 
Mann-Whitney U test, the value of p < 0.05 was 
considered significant. 
 
All experimental protocols involving animals and their 
care were approved by the institutional animal care and 
used committee of International Islamic University 
Malaysia (Ref. no. 2015-6-34-IACUC-IIUM/) and the 
experimental protocols followed the “Guide for the care 
and use of laboratory animals”.9  
 
Results  
 
Liver function tests. The changes in the liver function 
profile of diabetic and Non-diabetic rat are illustrated in 
Table 1. The result shows a significant reduction in total 
protein and albumin level in the serum of diabetic rats. 
The serum level of ALP, ALT, AST, as well as total 
bilirubin, was significantly higher in the diabetic rats 
group compared with control group. 
 
Lipid profile and blood glucose test. Table 2 showed 
the lipid profile and blood glucose of diabetic and Non-
diabetic rat. Lipid profile of diabetic rats was 
characterised by an extremely significant elevation (p < 
0.01) in the levels of low-density lipoprotein (LDL) and 
triglyceride (TG), compared with the normal animals. 
The high-density lipoprotein (HDL) level is slightly 
decreased in the diabetic group, but it was not 
statistically significant (p > 0.05). Fasting glucose sugar 
(FBS) level increased significantly in the diabetic group 
(p < 0.01), compared with control group. 
 
Kidney function tests. The renal function parameters of 
diabetic and Non-diabetic rat are illustrated in Table 3. 
Renal profile of diabetic rats was characterised by a 
significant decrease in calcium, chloride and sodium 
serum level compared with control group (p < 0.05). 
While serum urea concentration showed a significant 
increase (p < 0.05) in STZ-diabetic rats.  
 
Hematological tests. The hematological profile of 
diabetic and normal rats are illustrated in Table 4. Red 
blood cell (RBC) count of the diabetic group showed a 
significant decrease (p < 0.05) compared with control 
group. The significant decline (p < 0.05) in the levels of 
mean corpuscular haemoglobin concentration (MCHC) 
and corpuscular Hb concentration mean (CHCM) were 
noted in diabetic rats. In contrast, there is a significant 
increase (p < 0.05) in the levels of mean corpuscular 
volume (MCV), mean corpuscular haemoglobin (MCH) 
and cellular haemoglobin (CH) was observed in the 
diabetic animals. About White blood cell (WBC), the 
present data showed a significant decrease (p < 0.05) in 
STZ treated group when compared with control group. 
On the other hand, there was a substantial increase (p < 
0.05) in Neutrophils (NEUT) and Monocytes (MONO). 
On the contrary, Lymphocytes (LYMP) and Leucocytes 
(LUC) showed a significant decrease (p < 0.05) when 
compared with normal control group. 
 
Histological observation. The normal histological 
structure of the pancreas is observed in (Figure. 1A); the 
pancreatic islet cells are embedded within the acinar 
cells and surrounded by a fine capsule. The pancreatic 
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islets of diabetic rats revealed severe pathological 
changes. The STZ pancreas showed destructed 
pancreatic islets with severe atrophy and massive loss of 
islet cells leading to large cytoplasmic vacuoles; some 
vacuoles are filled with a semifluid-like material and 
dilated sinusoids with eosinophilic material deposition. 
The pathological changes also extended into 
surrounding exocrine tissue. The size of the exocrine 
cells was shrunken with the occurrence of peripheral 
widening between pancreatic acinar and islet cells 
(Figure 1B). Microscopical examination of liver 
sections from the control rats showed normal 
architectures of the hepatocytes with distinctive central 
veins (Figure 1C). On the other hand, liver sections of 
the STZ treated group showed dilated and congested 
sinusoid with mild free (hemorrhage) RBC in the 
interstitial tissue, centrilobular necrosis, infiltration of 
inflammatory cells, deposition of amyloid material and 
fibrosis surrounding the portal tried (Figure 1C). 
 
 
Table 1. Liver Function Tests of the Experimental Groups 
 
Parameters None- diabetic group (Control) Diabetic group (STZ group) 
Total protein (g/L) 74.00 ± 1.52 65.80 ± 2.08** 
Albumin (g/L) 40.45 ± 1.53 25.61 ± 2.59** 
ALP (U/L) 73.35 ± 3.78 606.02 ± 261.37** 
ALT (U/L) 51.44 ± 4.65 127.80 ± 10.44** 
AST (U/L) 144.84 ± 8.80 193.53 ± 12.20* 
Total bilirubin (umol/L) 0.94 ± 0.12 2.23 ± 0.70* 
Direct bilirubin (umol/L) 0.68 ± 0.10 1.36 ± 0.40 
Indirect bilirubin (umol/L) 0.28 ± 0.07 0.86 ± 0.35 
 
Data are presented as mean ± SEM and Mann-Whitney U test is used, p < 0.05 is taken as statistically significant at a 95% confidence interval. 
*significant (p < 0.05), **high significant (p < 0.01) 
 
 
Table 2. Lipid profile & Fasting Blood Sugar (FBS) Tests of the Experimental Groups 
 
Parameters (mmol/L) Non- diabetic group (Control) Diabetic group (STZ group) 
LDL 0.22 ± 0.04 0.90 ± 0.42** 
HDL 1.73 ± 0.09 1.36 ± 0.14 
TG 0.51 ± 0.02 1.31 ± 0.32** 
TC 2.02 ± 0.10 1.78 ± 0.15 
FBS 3.90 ± 0.08 29.62 ± 1.06** 
 
Data are presented as mean ± SEM and Mann-Whitney U test is used, p < 0.05 is taken as statistically significant at a 95% confidence interval. **high 
significant (p  < 0.01) 
 
 
Table 3. Kidney Function Tests of the Experimental Groups 
 
Parameters Non- diabetic group (Control) Diabetic group (STZ group) 
Creatinine (umol/L) 26.94 ± 2.12 25.23 ± 1.71 
Uric acid (umol/L) 82.80 ± 12.08 79.11 ± 9.49 
Urea (mmol/L 5.45 ± 0.71 13.18 ± 2.85* 
Calcium (mmol/L) 2.42 ± 0.10 2.12 ± 0.065* 
Chloride (mmol/L) 102.53 ± 0.55 91.02 ± 1.53* 
Potassium (mmol/L 4.81 ± 0.21 5.25 ± 0.39 
Sodium (mmol/L) 138.88 ± 0.24 133.48 ± 1.52* 
Phosphate (mmol/L) 2.10 ± 0.07 1.87 ± 0.19 
 
Data are presented as mean ± SEM and Mann-Whitney U test is used,  p < 0.05 is taken as statistically significant at a 95% confidence interval. 
*significant (p < 0.05). 
A Comprehensive Study of Chronic Diabetes Complications 
Makara J. Health Res.  August 2016 | Vol. 20 | No. 2 
51 
Table 4. Hematological Tests of the Experimental Groups 
 
Parameters None- diabetic group (Control) Diabetic group 
RBC (10^12 /L 8.39 ± 0.21 7.17 ± 0.47* 
HGB (g/d L) 14.45 ± 0.41 13.23 ± 1.04 
HCT (%) 44.62 ± 0.97 42.45 ±3.40 
MCV (f L) 53.25 ± 0.25 59.00 ± 1.41* 
MCH (pg) 17.28 ± 0.10 18.38 ± 0.43* 
MCHC (g/d L) 32.43 ± 0.30 31.18 ± 0.21* 
CHCM (g/d L) 33.48 ± 0.43 32.03 ± 0.38* 
CH (pg) 17.78 ± 0.17 18.78 ± 0.50* 
RDM (%) 12.70 ± 0.12 15.60 ±1.17 
HDW g/d L) 2.32 ± 0.02 2.52 ± 0.28 
PLT (10^9 /L) 1389.50 ± 45.98 594.00 ± 66.68* 
MPV (f L) 7.40 ± 0.07 7.43 ± 0.25 
WBC (10^9 /L) 16.40 ± 2.07 4.54 ± 0.65* 
NEUT (%) 4.35 ± 0.48 20.75 ± 3.47* 
LYMP (%) 65.38 ± 2.96 31.10 ± 8.35* 
MONO (%) 14.50 ± 1.11 39.83 ± 4.76* 
EOS (%) 4.08 ± 1.87 0.85 ± 0.56 
BASO (%) 0.28 ± 0.06 0.55 ± 0.45 
LUC (%) 11.43 ± 0.33 6.98 ± 1.03* 
 
Data are presented as mean ± SEM and Mann-Whitney U test is used,  p < 0.05 is taken as statistically significant at a 95% confidence 
interval. *significant (p < 0.05). 
 
 
 
 
Figure 1.  Photomicrographs of Sections of: A). Pancreas of Control Group, Showing Normal Histological Structure. B). 
Pancreas of STZ Treated Rats, Showing Severe Atrophy and Massive Loss of Islet Cells, Large Cytoplasmic 
Vacuoles (v), Dilated Sinusoids with Eosinophilic Material Deposition (Arrow), and Degeneration Extends to 
Exocrine Acinar Cells (Curved Arrow). C). Liver of Control Group, Showing Normal Architecture. D). Liver of 
STZ Treated Rats, Showing Centrilobular Necrosis (Arrow), Kupffer Cells Infiltration (Head Arrow), Lymphocytic 
Infiltration and Fibrosis Near the Portal Tried (pt), Amyloid Material and Fibrosis Near the Portal Tried (Curved 
Arrow) (H&E x 200) 
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The kidney of control rats showed normal histological 
structures of the glomeruli, and renal tubules (Figure. 
2A). The kidney sections of diabetic rat exhibited 
tubular damage with fatty degeneration, dilated  tubular 
lumen lined with degenerated epithelium and apoptotic 
cells, congested blood vessels, shrunken glomeruli, 
widening of Bowman space, thickening of the arterial 
wall, and periarterial mononuclear infiltration (Figure. 2 
B&C). Sections of the wall of the heart of the of control 
rats showed normal histological appearance. The 
myocardium showed branching, anastomosing cylinders 
myocardium with centrally located oval basophilic 
nuclei (Figure. 2D). The myocardium of STZ rat 
revealed histological changes in the form of 
disorganisation, distortion, degeneration and 
hyalinization of the myocardial fibers, increased 
interstitial space with chronic inflammatory infiltration, 
thickened vascular wall, dilated and congested blood 
vessels with eosinophilic material deposition (Figure. 
2E). The spleen of control rats showed normal white 
and red pulp and with distinctive marginal zone (Figure. 
3A).  Examination of STZ diabetic rat’s spleen sections 
revealed degeneration of the marginal zone of the white 
pulp. In addition to apoptosis and necrosis of 
lymphocytes in the red and white pulps, a decrease in 
the lymphocytes and macrophages in the germinal 
centre, and thickening of the central arteriolar wall, 
congested and distended venous sinuses and amyloid-
like material deposition and fibrosis in red and white 
pulps (Figure. 3 B&C). The adrenal glands of control 
rats revealed normal appearance and  were seen 
surrounded by thin connective tissue capsule (Figure. 
3D). Sections of STZ diabetic rat’s adrenal glands 
showed severe hydropic degenerative and pycnotic 
changes in zona glomerulosa and zona fasciculate, 
dilated and congested sinusoids in the cortex, thickened 
capsule and blood vessel wall and lobulation and 
fibrosis in the cortex (Figure. 3E). 
  
 
 
Figure 2.  Photomicrographs of Sections of: A; Kidney of Control Group, Showing Normal Histological Structure. B and C; 
Kidney of STZ Treated Rats, Showing Shrunken Glomeruli, Dilated Bowman Space (s), Dilated Lumen of PCTs 
Lined with Degenerated Epithelium with Apoptotic Cells (Arrow), Abnormal Renal Tubules with Fatty 
Degeneration (f) and Mononuclear Infiltration(Curved Arrow). D; Myocardium of Control Group, Showing 
Normal Architecture. E; Myocardium of STZ Treated Rats, Showing Degeneration of the Myocardial Fibers 
(Arrow), Increased Interstitial Space(s), Dilated and Congested Blood Vessels with Eosinophilic Material 
Deposition (Curved Arrow). (H&E x A, B, C &D; 200, E; 400) 
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Figure 3.  Photomicrographs of Sections of: A; Spleen of Control Group, Showing Normal Histological Structure. B and C; 
Spleen of STZ Treated Rats, Showing Congestion of Splenic Tissues with Markedly Distended Venous Sinuses 
(Arrows). Amyloid-like Material Deposition (Head Arrows), Degeneration of the Marginal Zone, Apoptosis and 
Necrosis of Lymphocytes in the Red and White Pulps (Stars). Decline in the Number of Macrophages and 
Lymphocytes in the Germinal Center (g), and Thickening of the Central Arteriolar Wall. D; Adrenal Gland of 
Control Group, Showing Normal Architecture. E; Adrenal Gland of STZ Treated Rats, Showing Severe Hydropic 
Degenerative Changes in Zona Glomerulosa and Zona Fasciculate (Arrows), Thickened Capsule and Blood Vessel 
Wall (Curved Arrow) and Lobulation and Fibrosis in the Cortex. (H&E x A, B, &D; 200, C&E; 400) 
 
 
Discussion  
 
Diabetes mellitus is a metabolic disease distinguished 
by numerous groups of disorders that disturb the 
metabolism of carbohydrates, fat, and protein.10 In the 
present study, diabetes induced by STZ was associated 
with many complications. These complications include 
dyslipidemia, electrolyte imbalance, hepatic enzymes 
disturbance and hematological abnormalities. Diabetes 
induced by STZ has been related to abnormal lipid 
profile. The increases in plasma triacylglycerol and low-
density lipoprotein (LDL), and the decrease in high-
density lipoprotein (HDL) indicated significant 
dyslipidemia in diabetic rats; similar results were 
obtained by several studies in human and experimental 
diabetes.11,12 Some biochemical mechanisms have been 
suggested as responsible for the hypertriglyceridemia in 
diabetes. These include an increase in the activity of 
hormone-sensitive lipase, which catalyses the 
mobilisation of fatty acids from triacylglycerol stored in 
adipocytes.13,14 Therefore, the larger amounts of fatty 
acids returning to the liver are reassembled into 
triacylglycerols and secreted in VLDL. It has 
additionally been reported that the activity of 
lipoprotein lipase is reduced in diabetes, and this 
explained the diabetic hypertriglyceridemia.12 
 
Hepatic enzymes level of AST, ALT, and ALP were 
higher in the STZ diabetic rats. STZ has been noticed to 
have a significant role in the alteration of liver 
function.15 Associated with the progress of diabetes, a 
state of decreased total protein concentration is 
evidenced, which may have resulted from either 
hyperfiltration induced diabetic nephropathy and/or 
increased protein catabolism.16 
 
In the present study, diabetes was associated with 
electrolyte imbalance, where a decrease in serum Na, 
Ca, and Cl, with increased serum K were recorded, this 
might be due to the osmotic diuresis produced by the 
state of hyperglycemia that causes marked urinary loss 
of water and electrolytes.17 Concerning sodium, 
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additionally, there is a translocation of Na+, K+-ATPase 
pumps from the basolateral membrane of proximal 
convoluted tubules to the cytosol, which leads to a 
decrease in sodium pumping from renal tubules to the 
blood.18 As for serum calcium, previous studies 
demonstrated lower concentration level associated with 
a reduction in the mineral content of bone and increased 
urinary excretion of calcium and phosphate in STZ 
diabetic rats. The decrement of calcium was related to 
several factors such as metabolic changes including 
chronic acidosis; insulin deficiency, impaired 
parathyroid hormone action and changed vitamin D 
metabolism have been implicated.19 The urea level, 
which has been considered as a significant marker of 
diabetic nephropathy was increased in the STZ-induced 
diabetic group, and this result is consistent with the 
other study.20 It has been proved that the metabolic 
defects observed in uncontrolled diabetes lead to 
gluconeogenesis and consequently urea production.12 
This previous result is consistent with the reduction in 
the total serum protein level of diabetic rats in the 
present study. 
 
Hematological evaluations revealed significant (p < 
0.05) decline in the red blood cell (RBC) values in 
diabetic rats. These observations agree with existing 
literature that anemia is a common pathophysiology 
associated with diabetes mellitus.21 Recurrent or 
persistent hyperglycemia during diabetes causes non-
enzymatic glycosylation of body proteins. Some 
biomolecules, such as Hb and RBC membrane proteins, 
are modified by glycation. RBC membrane hemolysis is 
due to the glycosylation of membrane proteins and lipid 
peroxidation, and this may lead to anemia.22 The reduced 
levels of WBC, PLT, and LYMP in diabetic rats 
indicate suppression of the immune system. These cells 
have an important role in identifying and eliminating 
pathogens, either by attacking larger pathogens through 
contact or by phagocytosis. They have the essential part 
of the innate immune system, which is also an important 
mediator of the activation of the adaptive immune 
system.23 In addition to the previously mentioned, there 
are many abnormalities regarding MCV, MCH, CH, 
MCHC, CHCM, NEUT, MONO, and LUC. Diabetes 
mellitus is responsible for the abnormalities in the 
function, metabolism, and morphology of blood cells as 
well as the coagulation system. Numerous abnormalities 
are the consequence of hyperglycemia and protein 
glycosylation. Even though they are not frequent 
manifestations of diabetes, hematologic complications 
can result in anemia, infection, and hypercoagulability. 
Most hematologic deviations are reversible with effective 
metabolic control.24 
 
Histologically, STZ is well known for its selective 
pancreatic islet β-cell cytotoxicity and has been 
extensively used to induce diabetes mellitus in animals. 
It interferes with cellular metabolic oxidative 
mechanisms. The decrease in cellularity within islets of 
Langerhans observed in the present study reflects the 
cytotoxicity of STZ.25 STZ treatment in rats exhibited 
shrunken islets of Langerhans with cytoplasmic 
vacuolation of their cells associated with negative 
insulin immunoreaction; ultrastructurally the β-cells 
showed darkly stained nuclei with marked loss of 
granules.26 The pathoanatomical changes in liver of 
diabetic animals have been previously reported.27,28 
Liver, an insulin-dependent tissue, playing a pivotal role 
in glucose and lipid homeostasis, is severely affected by 
diabetes.29 Previous studies have detected moderate to 
severe degeneration of the hepatocytes.6 The structural 
changes in kidneys could be attributed to altered 
metabolism in diabetes and the subsequent effects on 
the increased renal threshold for hyperglycemia.30 
Previous studies on the long-term effects of diabetes in 
experimental animals show glomerular nephropathy 
along with tubular and interstitial abnormalities
. 
31
 
Massive inflammatory infiltrates in the interstitial tissue 
as well as vacuolar degeneration of tubular epithelial 
cells and renal glomeruli.30,32 The anomaly in the 
cardiac muscle in the present study is consistent with 
the earlier animal study, which demonstrated severe 
necrotic cardiac muscle in STZ diabetic rats. Previous 
observation by an electron microscope showed the 
disappearance of the myofilaments organisation and 
pyknic mitochondria in the myocardium of diabetic 
rats.33 The histopathological changes in heart could be 
attributed to the subsequent effects of hyperglycemia 
which induces degenerative changes in the tissues along 
with cardiomyopathy and nephropathy by oxygen free 
radicals.34 The abnormalities in the zona glomerulosa 
and zona fasciculate in addition to the cortical fibrosis 
and thickened blood vessel wall of the adrenal gland in 
this study could be attributed to the hormonal changes 
as mentioned by the previous investigation.35 In the 
present study, the diabetic rats exhibited numerous 
abnormal histopathological features of the spleen 
characterised by apoptosis of the lymphocyte and 
necrosis in the white, and red pulps are consistent with 
the previous observation that demonstrated extensive 
parenchymal fibrosis involving the marginal zone and 
follicular areas of the white pulp.36    
 
Conclusions 
 
This research regards as a comprehensive study of 
diabetes complications in an animal model. After six 
months, STZ-diabetic rats showed severe pathological 
changes in the Islets of Langerhans, liver, kidney, spleen, 
cardiac muscle and adrenal gland. These pathological 
changes associated with the deterioration of the liver 
and renal functions, lipid profile, and haematological 
parameters. On the other hand, this study can be used as 
a reference for many biochemical and histopathological 
abnormalities of diabetes complications in an animal 
model for other researchers. The results of this research 
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can be used in studies which looking at the treatment of 
diabetes complications for comparison purposes. 
Researchers recommend following the method of 
diabetes induction which has been used because they 
showed excellent results. 
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